Welcome to AlterOnco, BraimIA, Drop, Emy, Frozmetics, IASO Discovery, Kahivac Therapeutics, Luminnov, Mantalys, Olea Medical, Oncoways, RNA Lead, SkinBionics, SunWaves Med Tech, Ultradoc and VirtuBiopsy.
An AI assistant designed to save time and relieve the mental burden on healthcare practitioners, a provider of advanced post-processing services for MR and CT perfusion imaging, an innovative digital platform dedicated to pediatric oncology, an immunopeptidomics platform to explore the "dark genome" and design next-generation cancer vaccines... no fewer than 16 innovative companies have just joined the Eurobiomed community.
AlterOnco
AlterOnco proposes the development of an orchestration platform dedicated to oncology, enabling the automation of all or part of patient management workflows.
BraimIA
Markus Santé is an AI Assistant designed to save time and relieve the mental burden of healthcare practitioners. Designed using an Agentic AI approach, Markus-Santé is the French, transparent and reliable AI for healthcare practitioners. The BraimIA project has been in development for 2 years with a team of technical and business experts, a beta version is being used by over 300 practitioners and commercialization is scheduled for January 2026.
Drop
Drop is a project aimed at treating dry eyes. The company is proposing to set up a new process for accessing CSA (Autologous Serum Eye Drops) and innovative manufacturing processes designed to homogenize and facilitate the provision of this treatment, while reducing the cost of accessing the treatment.
Emy
Emy is a mental health support app that draws on the latest French advances in artificial intelligence (AI) to offer personalized, accessible and affordable support. The app enables natural, fluid interactions, simulating a conversation with a close friend, family member or healthcare professional (psychologist or psychiatrist). Emy is positioned as a true life companion, designed to accompany people going through emotional challenges, whether mild or more serious.
Frozmetics
Frozmetics, a company founded in January 2023, aims to transform the approach to skin care and treatment using cold technologies and exclusively natural ingredients. Its aim is to modulate the major biological functions that are deficient or diminished, particularly during skin aging, in order to restore optimal functioning.
IASO Discovery
IASO Discovery is a biotech specializing in the early phases of drug discovery. It is developing an innovative platform for the discovery (design/synthesis) and optimization of therapeutic oligonucleotides from the ARNA laboratory in Bordeaux, headed by Prof. Philippe Barthélémy and co-founder of the company. Its hybrid business model combines services and co-development.
Kahivac Therapeutics
Kahivac Therapeutics is a project to create an innovative biotechnology company specializing in immuno-oncology. Its mission is to discover and develop new therapies to help patients recover from cancer and improve their quality of life. The company will develop a disruptive immunopeptidomics platform that will explore the "dark genome" to design next-generation cancer vaccines.
LumInnov
LumInnov is developing Sunlution, an innovative skincare brand combining sun protection (SPF) with anti-aging and antioxidant action. The technology is based on encapsulation and cellular protection systems that enhance the efficacy of filters and absorb antioxidant active ingredients.
Mantalys
Mantalys is a Toulouse-based startup that grew out of public-sector laboratories. It designs lightweight, fast, high-performance AI solutions for image analysis, combining the power of deep learning with the elegance of evolutionary approaches. Its tailor-made algorithms require little training data, are easily deployable and have a minimal energy footprint. Finally, Mantalys develops an intuitive software suite integrating their own models for advanced scientific analysis.
Olea Medical
Provider of advanced MR and CT perfusion imaging post-processing services, Olea Medical designs medical imaging applications that improve diagnostic processes. Olea Medical's mission is to develop specialized software for medical image and diagnostic optimization, mainly in the field of emergency neurology.
Oncoways
Oncoways is an innovative digital platform dedicated to pediatric oncology. It centralizes patient information to optimize their follow-up and care in France. Thanks to real-time care coordination, piloted by the referring oncologist and enhanced by alerts based on data analysis via artificial intelligence, Oncoways is revolutionizing the management of care protocols for young cancer patients.
RNA Lead
RNALead 's mission is to provide its partners with a powerful, versatile and proven proprietary RNA delivery technology. The company supports its customers throughout their innovation journey, from early research phases to clinical applications, with a turnkey solution designed to meet the evolving requirements of modern gene and cell therapies.
SkinBionics
SkinBionics is a digital health solution that helps doctors detect skin abnormalities in vivo in real time. This is enabled by a non-diagnostic platform and device, based on the ABCDE methodology employed by dermatologists.
SunWaves Med Tech
SunWaves MedTech is a French medical technology company specializing in AI-enhanced medical supervision. Its SaaS platform combines digital biomarkers, certified connected objects and artificial intelligence to provide 24/7 monitoring of frail, chronic or convalescing patients. SunWaves relies on its own medical supervision centers and salaried medical teams to support care without taking the place of attending physicians.
Ultradoc
Ultradoc is developing an all-in-one connected medical device, enabling doctors to measure several health data simultaneously (heart rate, respiration, oximetry, etc.) for a complete and rapid diagnosis.
VirtuBiopsy
VirtuBiopsy is developing an AI algorithm for radiologists and oncologists. This solution combines the analysis of imaging results with the patient's metabolomic results for effective diagnosis of suspected cancer, while avoiding the need for conventional biopsy, which is invasive and sometimes painful.
